Chris Carroll x200

Chris Carroll BA, MA (King's College London), MSc (Sheffield), PhD (Cambridge)

Reader in Systematic Review and Evidence Synthesis

HEDS, ScHARR
The University of Sheffield
Regent Court, 30 Regent Street
Sheffield, S1 4DA

Office: 112 West Court

Tel: (+44) (0)114 222 0864
Fax: (+44) (0)114 222 0749

E-mail: c.carroll@sheffield.ac.uk

ORCiD: 0000-0002-6361-6182

Biography

I joined ScHARR in 2004 and was appointed as a Research Fellow in 2007. In early 2011 I was appointed Senior Lecturer in Health Technology Assessment (HTA) and was the first Course Director of the MSc in International Health Technology Assessment, Pricing and Reimbursement (iHTA), with responsibility for developing and running the programme. The MSc is now in its ninth year. In 2014 I was promoted to Reader and made a University Senate Fellow for Excellence in Learning and Teaching. I stepped down as Course Director of the iHTA programme in 2015 and returned to working for the ScHARR Technology Assessment Group (TAG) conducting appraisals for NICE (2015-2018). I was previously the Lead for the systematic reviewers in HEDS (2017-18), and in 2018 was appointed Deputy Director of Health Economics and Decision Science and the REF Co-ordinator for the School (Unit of Assessment 2). 

Research interests

  • Systematic review and evidence synthesis of medical, health and social science topics, including qualitative and mixed method evidence synthesis;
  • The Health Technology Assessment (HTA) process and related decision-making;
  • Research on research: research impact and the analysis of evidence informing healthcare decision-making;
  • Information retrieval and programme evaluation (implementation fidelity) research

Teaching Interests

  • I am interested in supervising research students in topics/areas such as systematic review and evidence synthesis methods, the health technology assessment (HTA) process, and implementation research.

Current projects

  • A qualitative evidence synthesis of the views and preferences of parents, family, health professionals and decision-makers regarding infant feeding in the context of infectious disease transmission risk. WHO commissioned (PI).
  • A qualitative evidence synthesis of the feasibility, acceptability, accessibility, sustainability and cost implications of Ready-to-Use-Therapeutic Foods (RUFT) with <50% proteins from milk products for uncomplicated severe acute malnutrition (SAM) in infants aged 6 months or older. WHO commissioned (PI: Andrew Booth).

Professional Activities

  • Member of the NICE Interventional Procedures Advisory Committee (IPAC) 2014-2020

Extended list of publications

Journal articles